Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine for the Treatment of Major Depression and Neuropsychiatric Co-morbidities After Traumatic Brain Injury (TBI)

NCT02845349 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02845349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02845349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine for the Treatment of Major Depression and Neuropsychiatric Co-morbidities After Traumatic Brain Injury (TBI)
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Withdrawn
Start date
October 31, 2016
Completion date
October 31, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, tbi